Exclusive | GSK Sees Cancer-Drug Pipeline Nearly Doubling Next Year After Dealmaking Spree - WSJ

Health By The Wall Street Journal • October 28, 2026, 8:10 PM UTC
⏱ 1 min read 👁 2 views
Direct Source Verification: This story is aggregated from The Wall Street Journal (wsj.com). Full reporting rights and copyright belong to the primary publisher.
Read on The Wall Street Journal ↗
Exclusive | GSK Sees Cancer-Drug Pipeline Nearly Doubling Next Year After Dealmaking Spree  WSJ
Exclusive | GSK Sees Cancer-Drug Pipeline Nearly Doubling Next Year After Dealmaking Spree  WSJ
Original Source
https://news.google.com/rss/articles/CBMivgFBVV95cUxPaUVQaE8zZllsVDViT0tzdk9vVG0wTWs0Y0tGZXJnMW44MlpkNnB1cldmbG5kOWVlQS1RT0hEeXJ3cUYwaFZaeUJ3clljZnYxYVRveV9CelZCX19lc3ZVVnV4cXZtVjdQOTZsb3RlamxrekxteUx5U1poMm0yQ3dlVy1pZlREd3k5QnJpcDY4T0xMZ2Q5elNpcTI0c0ZFeUhWbGxwOUZtN0JYSmFmUGx1OW5WYkQ2YmZvSExydFZB?oc=5
Visit The Wall Street Journal ↗
SHARE STORY:
𝕏 f in

Related Coverage in Health